Is it safe?
Can MDGL take a bad year?
Madrigal Pharmaceuticals, Inc. holds $498M more cash than debt, and is burning $52M a quarter, about 4.0 years of cover.
$498M
Net cash
- Net debt / EBITDA
- net cash
Net debt / EBITDA · no net borrowings to measure against earnings
- Altman Z-score
- 9.36
Altman Z-score · safe zone, above 3
- Cash runway
- 4.0 years
Cash runway · burning $52M a quarter at the current rate
Details›
- Total debtQ2 2026
- $341M
- Cash and short-term investments
- $839M
- Net cash
- $498M
- EBITDA, trailing twelve months
- −$321M
- Operating profit, trailing twelve months
- −$323M
- Debt / equity
- 0.65×
- Annualised volatilitytwo years of daily moves
- 53%
- Worst drawdown on file
- −82%
- Below its 52-week high
- −11%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.